Development of the first inner ear organoids by 3D bioprinting for pharmacological screening in hearing disorders: CILCARE announces strategic agreement with CTIBIOTECH and SATT AxLR
CTIBIOTECH has been selected by SATT AxLR and CILCARE to develop the OrgaEar project, a disruptive innovation in hearing disorders research. Hearing disorders are a growing public health crisis. The…
